These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 8870373

  • 1. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
    Molica S, Mannella A, Dattilo A, Levato D, Iuliano F, Peta A, Consarino C, Magro S.
    Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
    [Abstract] [Full Text] [Related]

  • 2. Comparative flow cytometric evaluation of bcl-2 oncoprotein in CD5+ and CD5- B-cell lymphoid chronic leukemias.
    Molica S, Mannella A, Crispino G, Dattilo A, Levato D.
    Haematologica; 1997; 82(5):555-9. PubMed ID: 9407720
    [Abstract] [Full Text] [Related]

  • 3. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A, Rolinski J, Wasik-Szczepaneko E, Kaluzny Z, Dmoszynska A.
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [Abstract] [Full Text] [Related]

  • 4. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M, Kusenda J, Babusíková O.
    Neoplasma; 2003 May; 50(6):408-15. PubMed ID: 14689061
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
    Scamardella F, Maconi M, Albertazzi L, Gamberi B, Gugliotta L, Brini M.
    Lab Hematol; 2006 May; 12(4):187-92. PubMed ID: 17118768
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M, Sukova V, Coupek P, Brychtova Y, Mayer J.
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [Abstract] [Full Text] [Related]

  • 15. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L, Vidriales MB, García-Laraña J, Sanz G, Moreno MJ, López A, Barrena S, Martínez R, Tormo M, Palomera L, Lavilla E, López-Berges MC, de Santiago M, de Equiza ME, Miguel JF, Orfao A.
    Clin Cancer Res; 2004 Nov 15; 10(22):7599-606. PubMed ID: 15569991
    [Abstract] [Full Text] [Related]

  • 16. Apoptosis of leukemic cells: a case report.
    Vrbanus L, Sucić M, Marković-Glamocak M, Ries S, Gjadrov-Kuvezdić K, Fabijanić I, Antulov J, Petrik J, Labar B.
    Coll Antropol; 2010 Jun 15; 34(2):705-11. PubMed ID: 20698159
    [Abstract] [Full Text] [Related]

  • 17. Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia.
    Huh YO, Keating MJ, Saffer HL, Jilani I, Lerner S, Albitar M.
    Am J Clin Pathol; 2001 Sep 15; 116(3):437-43. PubMed ID: 11554173
    [Abstract] [Full Text] [Related]

  • 18. Flow cytometry of p53 protein expression in some hematological malignancies.
    Koníková E, Kusenda J, Babusíková O.
    Neoplasma; 1999 Sep 15; 46(6):368-76. PubMed ID: 10732866
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells.
    De Fanis U, Romano C, Dalla Mora L, Sellitto A, Guastafierro S, Tirelli A, Bresciano E, Giunta R, Lucivero G.
    Oncol Rep; 2003 Sep 15; 10(3):653-8. PubMed ID: 12684639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.